Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0664 CHF | 0.00% | -2.64% | +44.35% |
10:03am | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
08/05 | Addex to Present at BioEURquity Europe 2024 | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.35% | 9.52M | |
+55.70% | 59.34B | |
+42.83% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- ADXN Stock
- News Addex Therapeutics Ltd
- Addex Therapeutics : Starts Phase 2b/3 Trial of Dipraglurant in Dyskinesia Associated With Parkinson's Disease